An international pharmaceutical company KRKA joined ARPM
The list of company members of the Association of the Russian Pharmaceutical Manufacturers has increased by a new member- pharmaceutical company KRKA, that is specialized in the production of generic medicine.
The history of the company started 60 years ago when a small pharmaceutical lab was opened in Novo Mesto, Slovenia. Today KRKA is an international pharmaceutical company that is one of the leaders in producing of generic medicine, and its products are presented in over 70 countries.
The main products of the company are both prescribed and over the counter medicine, cosmetics, and veterinary medicine. The company is primarily focusing on the production of high-quality generics. All the medicine of the company is produced under the GMP rules.
The company has its own production and logistics center KRKA-RUS, which was GMP certified by the European commission. KRKA supplies Russia, the EU, and other countries. The company produces 36 essential drugs in 168 drug forms, which accounts for over 50% of sales and quantity of drug sales in Russia. KRKA increases the portion of drugs that are produced at the Russian plant.
“KRKA is a very well known company in Russia for its good products. I am confident that it’s membership will positively contribute the Association and improve the position of KRKA in Russia. Together we will have many more achievements and will make the pharmaceutical market in Russia more transparent and civilized,” said ARPM Director General, Victor Dmitriev.
“Membership in ARPM is a great opportunity for KRKA to improve drug provision of people with high quality and effective drugs,” PR of KRKA in Russia.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.